Related Experiment Video
Updated: Aug 25, 2025

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity
Alberto Mendoza-Valderrey1, Maite Alvarez2,3,4, Andrea De Maria5,6
1Rosalie and Harold Rae Brown Cancer Immunotherapy Research Program, Borstein Family Melanoma Program, Translational Immunology Department, Saint John's Cancer Institute, Santa Monica, CA 90404, USA.
Abstract:
In recent years, immunotherapy has become a powerful therapeutic option against multiple malignancies. The unique capacity of natural killer (NK) cells to attack cancer cells without antigen specificity makes them an optimal immunotherapeutic tool for targeting tumors. Several approaches are currently being pursued to maximize the anti-tumor properties of NK cells in the clinic, including the development of NK cell expansion protocols for adoptive transfer, the establishment of a favorable microenvironment for NK cell activity, the redirection of NK cell activity against tumor cells, and the blockage of inhibitory mechanisms that constrain NK cell function. We here summarize the recent strategies in NK cell-based immunotherapies and discuss the requirement to further optimize these approaches for enhancement of the clinical outcome of NK cell-based immunotherapy targeting tumors.
Insights
Natural killer (NK) cells offer a potent immunotherapy for various cancers due to their inherent tumor-targeting abilities. Research focuses on enhancing NK cell expansion, microenvironment, activity, and overcoming inhibitory signals to improve cancer treatment outcomes.
Area of Science:
- Immunology
- Oncology
- Cell Therapy
Background:
- Immunotherapy, particularly using natural killer (NK) cells, has emerged as a significant strategy against various cancers.
- NK cells possess inherent tumor-killing capabilities without requiring antigen specificity, making them promising for cancer treatment.
Purpose of the Study:
- To review and summarize recent advancements in NK cell-based immunotherapies for cancer treatment.
- To discuss strategies for optimizing NK cell therapies to improve clinical outcomes in oncology.
Main Methods:
- Review of current research and clinical strategies in NK cell immunotherapy.
- Analysis of approaches including NK cell expansion, microenvironment modulation, activity redirection, and inhibition blockage.
Main Results:
- Multiple strategies are being developed to enhance NK cell anti-tumor properties.
- These include optimizing NK cell expansion for adoptive transfer and creating supportive microenvironments.
Conclusions:
- NK cell-based immunotherapies hold great promise for cancer treatment.
- Further optimization of existing strategies is crucial for maximizing their clinical efficacy against tumors.
More Related Videos
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Targeted Cancer Therapies
There are several types of targeted therapies against...

